Healthcare has gotten good at finishing things. Discharge instructions are handed over. Follow-ups are scheduled. Portal accounts are created. Bills go out on time. Every one of those is a
Why Generative AI Isn’t Enough: The Case for Causal Reasoning in Medicine
A few years ago, I started experiencing symptoms I couldn’t explain, and no one could explain them either. Fatigue that wouldn’t lift, heart palpitations, an inability to lose weight regardless
New Bill Led by Democrats Aims to Cap Medicare Out-of-Pocket Costs
A group of Democratic senators introduced a new bill on Thursday that would create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries. The Medicare Cost Cap Act was
EMA: Amgen, Vifor Inflammatory Drug’s Benefits No Longer Outweigh Risks
Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory. The move follows an FDA proposal
Documentation Tools Aren’t Just for Doctors: Inside Reid Health’s Deployment of Abridge’s Nurse Tech
The clinical burnout crisis in the U.S. has been making headlines for years, and it continues to remain an unsolved problem. Stress and burnout levels have fallen a bit since
A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy
A metabolic disorder that leads to high levels of fat in the blood and life-threatening pancreatic complications now has its first FDA-approved medicine, an RNA-targeting therapy developed by Ionis Pharmaceuticals.
Why ‘Still Open’ Is the Wrong Way to Measure the Hospital Crisis
One of the most standard ways to measure the country’s hospital crisis is to count closures, but one hospital finance expert thinks that isn’t necessarily the right number to watch.
Why Most Healthcare AI Fails After the Pilot Phase
Healthcare isn’t struggling to adopt AI. In fact, the industry has moved quickly from early experimentation to widespread investment in tools designed to improve clinical decision-making, reduce administrative burden, and
New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer
The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for triple-negative breast cancer, tightening competition with a rival drug from the same
New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases
Michigan-based insurer Priority Health has teamed up with Garner Health, a digital platform that steers patients to high-performing doctors to lower costs, the companies announced on Wednesday. Priority Health serves









